SCHEMBL28116449

SCHEMBL28116449

C[C@]12CC[C@@H]3c4ccc(O)cc4C(CO)C[C@H]3[C@@H]1CC[C@H]2O

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 10/20 0.78
ESR1 P03372 8/20 0.78
ESR2 Q92731 5/20 0.78
LMNA P02545 5/20 0.74
MAPK1 P28482 3/20 0.74
SMN1; SMN2 Q16637 2/20 0.74
HSD17B10 Q99714 3/20 0.61
TSHR P16473 2/20 0.61
MEN1 O00255 2/20 0.61
KMT2A Q03164 2/20 0.61
MAPT P10636 2/20 0.61
CYP1A2 P05177 1/20 0.61
CYP2C9 P11712 1/20 0.61
CYP2C19 P33261 1/20 0.61
HIF1A Q16665 1/20 0.61
SLC22A1 O15245 1/20 0.61
AKR1B10 O60218 1/20 0.61
SLC22A3 O75751 1/20 0.61
ABCB11 O95342 1/20 0.61
ESRRB O95718 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL795604 1.00 CYP19A1 (0.78) CYP19A1ESR1ESR2LMNAMAPK1
SCHEMBL6346289 1.00 CYP19A1 (0.78) CYP19A1ESR1ESR2LMNAMAPK1
SCHEMBL2846408 1.00 CYP19A1 (0.78) CYP19A1ESR1ESR2LMNAMAPK1
SCHEMBL12544534 1.00 CYP19A1 (0.78) CYP19A1ESR1ESR2LMNAMAPK1
SCHEMBL6346280 1.00 CYP19A1 (0.78) CYP19A1ESR1ESR2LMNAMAPK1
SCHEMBL2842300 1.00 CYP19A1 (0.78) CYP19A1ESR1ESR2LMNAMAPK1
SCHEMBL796194 1.00 CYP19A1 (0.78) CYP19A1ESR1ESR2LMNAMAPK1
SCHEMBL795609 1.00 CYP19A1 (0.78) CYP19A1ESR1ESR2LMNAMAPK1
SCHEMBL16480227 0.91 CYP19A1 (0.78) CYP19A1ESR1ESR2LMNAMAPK1
SCHEMBL14190685 0.88 CYP19A1 (0.62) CYP19A1ESR1ESR2LMNAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106255501-A 6-substituted estradiol derivatives for the treatment of alzheimer's disease 恩德切有限责任公司 2016-12-21 CN disclosed